Immuron Ltd

Research Immuron Ltd (IMRN) on Bullrun: market cap USD 6.19M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIMRN
• ExchangeNASDAQ
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 6.19M
• Financial periodQ4 2025
• RevenueUSD 7.48M
• Net income-USD 4.65M
• Free cash flow-USD 4.70M
• Gross margin63.7%

Valuation Snapshot

latest market cap is USD 6.19M.

About Immuron Ltd

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection;

Frequently asked questions

What is Immuron Ltd's market cap?

Immuron Ltd's market capitalization is USD 6.19M.

What does Immuron Ltd do?

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products.